Brief: Targovax Announces Clinical Trial Collaboration With Agenus

Circio Holding ASA

15/12/2022 06:19

Dec 15 (Reuters) - Targovax ASA  TRVX.OL :
    * ANNOUNCES CLINICAL TRIAL COLLABORATION WITH AGENUS TO TEST
TG
MUTANT RAS VACCINATION IN PANCREATIC CANCER
    * TRIAL HAS BEEN GIVEN APPROVAL TO PROCEED BY US FOOD AND
DRUG
ADMINISTRATION (FDA), AND WILL BE ACTIVATED ON DECEMBER 15

Source text for Eikon:  ID:nObiYQdPWa 
Further company coverage:  TRVX.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))